IRF4 and metabolic dysfunction-associated steatohepatitis: Next, we verified that skeletal muscle-derived FSTL1-mediated NASH progression with regards to hepatic lipid metabolism, fibrosis, and inflammation in vivo when specific IRF4 deletion was induced in skeletal muscles.